Codexis (CDXS) Current Deferred Revenue (2010 - 2026)
Codexis (CDXS) recorded quarterly Current Deferred Revenue of $866000.0 in Q1 2026, down 88.25% quarter-over-quarter from $7.4 million in Q4 2025, and up 97.72% on a YoY basis from $438000.0 in Q1 2025.
Codexis (CDXS) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Codexis' Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $866000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 97.72% year-over-year to $866000.0; the TTM figure through Mar 2026 stood at $866000.0 (up 97.72% YoY), while the FY2025 annual figure was $7.4 million, up 1537.56% from the prior year.
- Current Deferred Revenue was $866000.0 for Q1 2026 at Codexis, down from $7.4 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $28.9 million in Q1 2023 to a low of $100000.0 in Q2 2025.
- Historically, Current Deferred Revenue has averaged $6.7 million across 5 years, with a median of $5.1 million in 2022.
- Biggest YoY gain for Current Deferred Revenue was 1537.56% in 2025; the steepest drop was 98.98% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $5.4 million in 2022, then tumbled by 75.75% to $1.3 million in 2023, then tumbled by 65.38% to $450000.0 in 2024, then surged by 1537.56% to $7.4 million in 2025, then plunged by 88.25% to $866000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $866000.0 (Q1 2026), $7.4 million (Q4 2025), and $396000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 866,000.00 |
| Dec 31, 2025 | 7.37 Mn |
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Sep 30, 2024 | 10.62 Mn |
| Jun 30, 2024 | 9.80 Mn |
| Mar 31, 2024 | 9.86 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 9.24 Mn |
| Jun 30, 2023 | 20.64 Mn |
| Mar 31, 2023 | 28.88 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 5.07 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Jun 30, 2021 | 500,000.00 |